LeCun | AuntMinnieEurope

Median gets CE marking for lung cancer screening software

By AuntMinnie.com staff writers

The CE marking follows the U.S. Food and Drug Administration (FDA)'s 510(k) clearance of eyonis LCS in February.

July 6, 2026

99% wasn't enough: How persistence in imaging changes the picture

By Claudia Tschabuschnig

Two patient stories told at the European Parliament proved that a second look can change everything.

July 6, 2026

European Parliament, Brussels. Policymakers, clinicians, and patient representatives at the 'Imaging Saves Lives' event, July 2.

PET/MRI can reduce the need for biopsies in prostate cancer

Prostate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.

July 2, 2026

A visual abstract of the study.

Quibim launches AI breast MRI tool across Europe, UK

By AuntMinnieEurope.com staff writers

The tool, QP-Breast, highlights suspicious areas on MRI and generates reports from imaging findings.

July 2, 2026

Qp Breast Press 02

Imaging takes center stage in Europe's Safe Hearts Plan

By Claudia Tschabuschnig

Radiology and nuclear medicine are poised to play a central role in implementing the European Commission's Safe Hearts Plan, speakers said during a joint ESR/EANM event in Brussels.

July 2, 2026

The Safe Hearts Plan aims to shift healthcare systems toward prevention, earlier diagnosis, and more personalized care.

AuntMinnieEurope.com CT Insider

By Claudia Tschabuschnig

This Insider tracks the muscle hiding in plain sight on coronary CT, the guesswork still baked into contrast agent safety, and Germany's screening rollout hitting real-world friction.

July 1, 2026

GE HealthCare, University Hospital Essen open nuclear medicine center

By AuntMinnieEurope.com staff writers

The center features the first installation of GE HealthCare's StarGuide GX SPECT/CT scanner.

July 1, 2026

Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?

By Claudia Tschabuschnig

Choosing an alternative contrast agent after an allergic reaction often falls to clinical judgment. A new review examines whether side-chain chemistry can make that decision a little more evidence based.

July 1, 2026

Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.

Low muscle density on coronary CT linked to heart risk

Patients with skeletal muscle attenuation below the median had a higher risk of mortality and myocardial infarction.

June 30, 2026

An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.

Medneo acquires Ramsay Diagnostics UK mobile imaging fleet

By AuntMinnieEurope.com staff writers

Medneo is acquiring Ramsay Diagnostics UK's mobile MRI and CT fleet and a six-year contract to provide mobile imaging services.

June 30, 2026

Mri Scanner2 400

Ratio Therapeutics signs Ac-225 supply agreement with PanTera

By AuntMinnie.com staff writers

Deal will support Ratio's alpha therapy programs.

June 30, 2026

Business Deal Corporate 400

GE HealthCare offers upgrades for interventional systems

By AuntMinnie.com staff writers

Upgraded systems also qualify for GE HealthCare's Tube Watch and OnWatch Predict service options.

June 29, 2026

Page 1 of 1326